 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || Proair digihaler (albuterol sulfate) / Teva, AirDuo Digihaler (salmeterol/fluticasone proprionate) / Teva
Enrollment closed, Heterogeneity: Teva Asthma Predictive Analytics Study (clinicaltrials.gov) - May 9, 2023
P4, N=101, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Active, not recruiting
- |||| Proair digihaler (albuterol sulfate) / Teva, AirDuo Digihaler (salmeterol/fluticasone proprionate) / Teva
New P4 trial, Heterogeneity: Teva Asthma Predictive Analytics Study (clinicaltrials.gov) - Aug 9, 2021
P4, N=100, Recruiting, Sponsor: University of Michigan
- | ArmonAir Digihaler (fluticasone propionate) / Teva, AirDuo Digihaler (salmeterol/fluticasone proprionate) / Teva
@TevaUSA announced that it launched its AirDuo Digihaler and ArmonAir Digihaler #digitalinhalers in the U.S. https://t.co/k4pvIz8ZkE (Twitter) - Oct 14, 2020
- || ArmonAir Digihaler (fluticasone propionate) / Teva, AirDuo Digihaler (salmeterol/fluticasone proprionate) / Teva
#TevaRespiratory, an affiliate of @TevaUSA, completed its #digitalinhaler portfolio today with the launch of two new products: #AirDuoDigihaler and #ArmonAirDigihaler. #Digihaler records inhaler-use data every time the cap is opened or a user inhales. #respiratory #inhaler (Twitter) - Sep 29, 2020